mRNA Purification via Chaotropic Salt Precipitation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying messenger RNA (mRNA) are costly and pose safety challenges due to the use of caustic or flammable solvents, especially in large-scale applications, and lack a safe and cost-effective approach to produce highly pure mRNA suitable for therapeutic use.

Innovation Solution

A method involving precipitation of mRNA in a high molar salt solution with an amphiphilic polymer, followed by capture and washing, which eliminates the use of volatile organic compounds and results in a highly pure mRNA composition free from contaminants like short abortive RNA species, double-stranded RNA, and residual solvents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If commercially-available chromatography systems (HPLC) are used for mRNA purification, then high purity mRNA can be obtained, but the process becomes expensive and challenging to implement

Engineering Contradiction:
ImprovemRNA purityVSAvoidprocess complexity and cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent changes the chemical parameters of the purification system by using chaotropic salts (guanidinium thiocyanate or guanidinium chloride) combined with alcohol precipitation instead of chromatography. This parameter change transforms the purification mechanism from adsorption-based chromatography to salt-induced denaturation and alcohol precipitation, achieving high purity while simplifying the process and reducing costs

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts and removes the problematic chromatography step from the purification process. Instead of using column-based separation, the method directly precipitates mRNA from the transcription mixture using alcohol in the presence of chaotropic salts, separating the desired product from contaminants through phase separation and centrifugation

Inventive Principle:
Principle #2Taking out (Extraction)

2Manufacturing precision

If organic mix extraction (phenol:chloroform:isoamyl alcohol) is used for mRNA purification, then high purity mRNA can be obtained, but safety and cost challenges arise due to caustic and flammable solvents

Engineering Contradiction:
ImprovemRNA purityVSAvoidsafety hazards from caustic and flammable solvents
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces expensive and hazardous phenol:chloroform:isoamyl alcohol extraction with a simpler, safer alcohol precipitation method using ethanol or isopropanol. These alcohols are less hazardous, more volatile (easier to remove), and achieve the same purification goal through a disposable-like single-use protocol rather than requiring careful handling of toxic phenol-based reagents

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the solvent system parameters from phenol-based organic extraction to alcohol-based precipitation. This parameter change eliminates the caustic and highly flammable phenol while maintaining effective separation of mRNA from contaminants through controlled precipitation conditions using safer alcohol solvents

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If traditional purification methods are used, then mRNA can be purified, but residual solvents and contaminants remain in the final product

Engineering Contradiction:
ImprovemRNA purificationVSAvoidresidual contaminants in final product
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent implements a continuous multi-step purification sequence: chaotropic salt treatment to denature proteins, alcohol addition to precipitate mRNA, centrifugation to separate phases, washing of the pellet to remove salts, and resuspension in sterile buffer. This continuous sequence of actions ensures thorough removal of contaminants at each stage, achieving high purity in the final product

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent uses chaotropic salts (guanidinium thiocyanate or guanidinium chloride) as intermediary agents that facilitate the separation process. These salts denature proteins and disrupt nucleic acid-protein complexes, enabling clean separation of mRNA from transcription enzymes and other contaminants. The salts are subsequently removed through washing steps, leaving no harmful residues in the final product

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a safe, cost-effective, and efficient means to produce highly pure mRNA for large-scale therapeutic applications, ensuring high integrity and purity without the use of caustic or flammable solvents, thereby addressing the existing challenges in mRNA purification.

Implementation Method 1

precipitating the mRNA in a suspension comprising a high molar salt solution and an amphiphilic polymer to provide precipitated mRNA

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Implementation Method 2

washing the precipitated mRNA captured in step b) with a wash solution to purify the precipitated mRNA

Methodology Applied
Scientific EffectWashing:

Data Source

PatentUS20230062449A1Methods for purification of messenger RNA
Publication Date: 2023.03.02 TRANSLATE BIO INC
  • US20230062449A1 patent drawing
  • US20230062449A1 patent drawing
  • US20230062449A1 patent drawing

AI summary

The present invention provides, among other things, methods for purifying high quality messenger RNA (mRNA) suitable for clinical use, without using any caustic or flammable solvents. The present invention is, in part, based on surprising discovery that mRNA can be successfully purified by selective precipitation and washing without using ethanol while maintaining integrity and high purity of mRNA. Thus, the present invention provides an effective, reliable, and safer method of purifying RNA from large scale manufacturing process therapeutic applications without using any caustic or inflammable solvents.